Scandion Oncology A/S (SCOL.ST)
SEK 0.01
(-5.04%)
SEK 0.01
(-5.04%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.96 DKK | 46.37% |
| 2022 | -1.79 DKK | -11.18% |
| 2021 | -1.61 DKK | -215.69% |
| 2020 | -0.51 DKK | 37.04% |
| 2019 | -0.81 DKK | -1.25% |
| 2018 | -0.80 DKK | -280.95% |
| 2017 | -0.21 DKK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.19 DKK | 29.63% |
| 2024 Q2 | -0.18 DKK | 83.74% |
| 2023 Q4 | -0.27 DKK | -8.0% |
| 2023 Q2 | -0.22 DKK | 4.35% |
| 2023 FY | - DKK | 46.37% |
| 2023 Q1 | -0.23 DKK | 28.13% |
| 2023 Q3 | -0.25 DKK | -13.64% |
| 2022 Q2 | -0.72 DKK | -80.0% |
| 2022 Q4 | -0.32 DKK | 51.52% |
| 2022 FY | - DKK | -11.18% |
| 2022 Q1 | -0.40 DKK | 16.67% |
| 2022 Q3 | -0.66 DKK | 8.33% |
| 2021 Q1 | -0.41 DKK | -57.69% |
| 2021 FY | - DKK | -215.69% |
| 2021 Q4 | -0.48 DKK | 0.0% |
| 2021 Q3 | -0.48 DKK | -23.08% |
| 2021 Q2 | -0.39 DKK | 4.88% |
| 2020 Q2 | -0.18 DKK | 5.26% |
| 2020 Q1 | -0.19 DKK | -3484.91% |
| 2020 Q4 | -0.26 DKK | -30.0% |
| 2020 FY | - DKK | 37.04% |
| 2020 Q3 | -0.20 DKK | -11.11% |
| 2019 Q4 | -0.01 DKK | 98.29% |
| 2019 FY | - DKK | -1.25% |
| 2019 Q3 | -0.31 DKK | 0.0% |
| 2019 Q2 | -0.31 DKK | -24.0% |
| 2019 Q1 | -0.25 DKK | 58.33% |
| 2018 Q2 | -0.22 DKK | -234.86% |
| 2018 Q4 | -0.60 DKK | -361.54% |
| 2018 FY | - DKK | -280.95% |
| 2018 Q1 | -0.07 DKK | 18.28% |
| 2018 Q3 | -0.13 DKK | 40.91% |
| 2017 Q3 | -0.06 DKK | 0.0% |
| 2017 FY | - DKK | 0.0% |
| 2017 Q4 | -0.08 DKK | -29.68% |